GSP Crop Science’s ₹400 crore IPO will open on March 16, 2026 and will be available to investors till March 18. The company has fixed the price band at ₹304-₹320 and 46 shares are placed in one lot.
GSP Crop Science IPO: A new IPO is going to open for investors in the stock market in the coming week. Agrochemical sector company GSP Crop Science is bringing its Initial Public Offering i.e. IPO. The company has fixed the price band for this issue and the date of application for investors has also been announced.
This IPO will open on 16 March 2026 and will remain open for investors till 18 March 2026. The company is planning to raise a total of Rs 400 crore through this issue. In view of the increasing possibilities in the agrochemical sector, this IPO has come into discussion among investors.
Price band fixed at ₹304 to ₹320
The company has fixed the per share price band for its IPO at Rs 304 to Rs 320. Investors can apply for the IPO by placing bids within this price range.
The lot size for applying in IPO has been kept at 46 shares. This means that the investor must apply for at least one lot.
If a retail investor applies in the upper price band i.e. Rs 320, he will have to invest approximately Rs 14,720 for one lot. This will be the minimum investment amount for retail investors.
The entire issue is worth ₹400 crore
The total IPO of GSP Crop Science is worth Rs 400 crore. This issue is divided into two parts which include both fresh issue and offer for sale.
The company will issue a fresh issue of Rs 240 crore through this IPO. Under this, about 75 lakh new shares will be issued in the market. Apart from this, Offer for Sale i.e. OFS of Rs 160 crore is also included. About 50 lakh shares will be sold in this.
Under OFS, promoters and existing shareholders will sell some part of their stake. These include Vilasben Vrajmohan Shah, Kappa Trust and Bhavesh Vrajmohan Shah.
Use of fresh issue amount
The company has stated in its Red Herring Prospectus i.e. RHP that the proceeds from the fresh issue will be mainly used to repay some of the outstanding debts of the company. Apart from this, this fund will also be used to meet general corporate needs.
The company believes that the capital raised through IPO will help in strengthening its financial structure and can also give impetus to future expansion plans.
Complete timeline of IPO
The IPO of GSP Crop Science will open on 16 March 2026 and close on 18 March 2026. During this period investors will be able to apply for IPO.
The process of allotment of shares is likely to be completed by March 20, 2026. After this, the money of those investors who are not allotted shares will be refunded. The company’s shares are likely to be listed on the stock exchange on March 24, 2026. On that day the stock may be available for trading on the stock exchange.
Issue Manager and Registrar
Equirus Capital Private Limited has been appointed as the book running lead manager for this IPO. This institution will handle the management and processing of the entire issue.
Whereas the work related to records and share allotment related to IPO will be handled by MUFG Intime India Private Limited. These institutions play an important role in smoothly completing the IPO process.
what does the company do
GSP Crop Science is a research based agrochemical company. This company produces a variety of products for the agricultural sector that help farmers increase crop protection and production.
The company mainly manufactures herbicides, insecticides, fungicides and plant growth enhancers. These products help farmers protect themselves from pests and diseases that damage crops. Along with this, they are also used in improving the productivity and quality of the crop.
Company’s focus on research and manufacturing
GSP Crop Science also emphasizes on research and technology for the development of its products. The company manufactures agrochemical products, both formulations and technical products. Formulations are products that contain active ingredients along with other admixtures. Whereas a technical product is a concentrated form of the active ingredient which is further used to make various formulations.
Comments are closed.